Skip to main content
Log in

Imaging the norepinephrine transporter with positron emission tomography: initial human studies with (S,S)-[18F]FMeNER-D2

  • Short communication
  • Published:
European Journal of Nuclear Medicine and Molecular Imaging Aims and scope Submit manuscript

Abstract

Introduction

(S,S)-[18F]FMeNER-D2 is a recently developed positron emission tomography (PET) ligand for in vivo quantification of norepinephrine transporter. A monkey occupancy study with the radioligand indicated that (S,S)-[18F]FMeNER-D2 can be useful for quantitative PET analysis. In this preliminary study, regional distributions in the living human brain were evaluated.

Materials and methods

Brain PET measurements were performed for a total of 255 min after the injection of 188.3 ± 5.7 MBq of (S,S)-[18F]FMeNER-D2 in four healthy male subjects. Regions of interests were drawn on the thalamus and the caudate in the coregistered MRI/PET images.

Results

(S,S)-[18F]FMeNER-D2 displayed good brain penetration and selective retention in regions rich in norepinephrine reuptake sites. The transient peak equilibrium was reached during the PET measurements. The ratios of radioactivity uptake in the thalamus to that in the caudate were 1.50 ± 0.06 for the time period of 90–255 min.

Conclusion

The present preliminary investigation indicates that (S,S)-[18F]FMeNER-D2 has suitable characteristics for probing the norepinephrine reuptake system with PET in the human brain.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Roy A, Pickar D, De Jong J, Karoum F, Linnoila M. Norepinephrine and its metabolites in cerebrospinal fluid, plasma, and urine. Relationship to hypothalamic–pituitary–adrenal axis function in depression. Arch Gen Psychiatry 1988;45:849–57.

    PubMed  CAS  Google Scholar 

  2. Biederman J, Spencer T. Attention-deficit/hyperactivity disorder (ADHD) as a norepinephrine disorder. Biol Psychiatry 1999;46:1234–42.

    Article  PubMed  CAS  Google Scholar 

  3. Schou M, Halldin C, Sovago J, Pike VW, Gulyas B, Mozley PD, et al. Specific in vivo binding to the norepinephrine transporter demonstrated with the PET radioligand, (S,S)-[11C]MeNER. Nucl Med Biol 2003;30:707–14.

    Article  PubMed  CAS  Google Scholar 

  4. Wilson AA, Johnson DP, Mozley D, Hussey D, Ginovart N, Nobrega J, et al. Synthesis and in vivo evaluation of novel radiotracers for the in vivo imaging of the norepinephrine transporter. Nucl Med Biol 2003;30:85–92.

    Article  PubMed  CAS  Google Scholar 

  5. Ding YS, Lin KS, Garza V, Carter P, Alexoff D, Logan J, et al. Evaluation of a new norepinephrine transporter PET ligand in baboons, both in brain and peripheral organs. Synapse 2003;50:345–52.

    Article  PubMed  CAS  Google Scholar 

  6. Schou M, Halldin C, Sovago J, Pike VW, Hall H, Gulyas B, et al. PET evaluation of novel radiofluorinated reboxetine analogs as norepinephrine transporter probes in the monkey brain. Synapse 2004;53:57–67.

    Article  PubMed  CAS  Google Scholar 

  7. Seneca N, Gulyas B, Varrone A, Schou M, Airaksinen A, Tauscher J, et al. Atomoxetine occupies the norepinephrine transporter in a dose-dependent fashion: a PET study in nonhuman primate brain using (S,S)-[18F]FMeNERD2. Psychopharmacology (Berl) 2006;188:119–27.

    Article  CAS  Google Scholar 

  8. Ghose S, Fujita M, Morrison P, Uhl G, Murphy DL, Mozley PD, et al. Specific in vitro binding of (S,S)-[3H]MeNER to norepinephrine transporters. Synapse 2005;56:100–4.

    Article  PubMed  CAS  Google Scholar 

  9. Schou M, Halldin C, Pike VW, Mozley PD, Dobson D, Innis RB, et al. Post-mortem human brain autoradiography of the norepinephrine transporter using (S,S)-[18F]FMeNER-D2. Eur Neuropsychopharmacol 2005;15:517–20.

    Article  PubMed  CAS  Google Scholar 

  10. Seneca N, Andree B, Sjoholm N, Schou M, Pauli S, Mozley PD, et al. Whole-body biodistribution, radiation dosimetry estimates for the PET norepinephrine transporter probe (S,S)-[18F]FMeNER-D2 in non-human primates. Nucl Med Commun 2005;26:695–700.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgement

The authors would like to thank Lilly Research Laboratories for providing the precursors and standards. We are grateful to all the members of the PET group at the Karolinska Institutet. We are also grateful to Dr. Pierre Lafolie at Karolinska Clinical Research for subject recruitment.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Christer Halldin.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Takano, A., Gulyás, B., Varrone, A. et al. Imaging the norepinephrine transporter with positron emission tomography: initial human studies with (S,S)-[18F]FMeNER-D2 . Eur J Nucl Med Mol Imaging 35, 153–157 (2008). https://doi.org/10.1007/s00259-007-0598-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00259-007-0598-8

Keywords

Navigation